Palvella Therapeutics, Inc Cash Flow Quality Index
Palvella Therapeutics, Inc cash flow quality index. Palvella Therapeutics, Inc (PVLA) has a Cash Flow Quality Index of -0.73x as of December 2023. Operating cash flow of $-13.70 Million is below net income of $18.69 Million, suggesting accrual-heavy earnings not yet converted to cash. See Palvella Therapeutics, Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Palvella Therapeutics, Inc (2023–2023)
Cash flow quality index of Palvella Therapeutics, Inc from 2023 to 2023. Historical Cash Flow Quality Index for Palvella Therapeutics, Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Palvella Therapeutics, Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Palvella Therapeutics, Inc Cash Flow Quality Index by Year (2023–2023)
Palvella Therapeutics, Inc cash flow quality index by year from 2023 to 2023. Year-by-year earnings quality comparison for Palvella Therapeutics, Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Palvella Therapeutics, Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.73x | $-13.70 Million | $18.69 Million | — |